AstraZeneca’s Groundbreaking Research: Revolutionizing Heart Failure and ATTR-CM Treatment
17 Jan 2025
AstraZeneca has always been at the forefront of addressing some of the most pressing health challenges, particularly in the cardiovascular, renal, and metabolic (CVRM) areas. Through cutting-edge research and a commitment to innovation, AstraZeneca is pioneering new therapies and advancing treatments for heart failure and transthyretin-mediated amyloid cardiomyopathy (ATTR-CM). In...
Read More
